Home

Emcure Pharmaceuticals Ltd PE Ratio

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

PE

33.4

Last updated on: Apr 01, 2025

Key Highlights

  • The P/E Ratio of Emcure Pharmaceuticals Ltd is 33.4 as of 01 Apr 09:58 AM .
  • The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1085 as of 01 Apr 09:52 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Emcure Pharmaceuticals Ltd

No data available

Company Fundamentals for Emcure Pharmaceuticals Ltd

Image

Emcure Pharmaceuticals Ltd

NSE: EMCURE

Share Price

₹ 1085.15

12.35 (1.15%)

stock direction

Last updated on: Apr 01, 2025

Market Price of Emcure Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Emcure Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
28 Mar 20251072.8
27 Mar 20251046.15
26 Mar 20251024.65
25 Mar 20251006.45
24 Mar 20251061.75
21 Mar 20251029
20 Mar 20251001.05
19 Mar 2025932.45
18 Mar 2025937.7
17 Mar 2025927.2

BlinkX Score for Emcure Pharmaceuticals Ltd

Asset Value vs Market Value of Emcure Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Emcure Pharmaceuticals Ltd20322
Sun Pharmaceutical Industries Ltd416393
Divis Laboratories Ltd153258
Cipla Ltd116434
Torrent Pharmaceuticals Ltd109469
Mankind Pharma Ltd99974

PE Ratio of Emcure Pharmaceuticals Ltd Explained

20322

Market cap

607

Earnings

33.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Emcure Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Emcure Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Emcure Pharmaceuticals Ltd

No data available

* All values are in %

About Emcure Pharmaceuticals Ltd

  • Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
  • Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
  • They are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics, which has enabled to reach target markets across over 70 countries, with a strong presence in India, Europe and Canada.

Emcure Pharmaceuticals Ltd News Hub

Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL

Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs

Read more

13 Aug 24

Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities

Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank

Read more

13 Aug 24

Emcure Pharmaceuticals consolidated net profit rises 10.48% in the June 2024 quarter

Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a

Read more

14 Aug 24

Emcure Pharmaceuticals to declare Quarterly Result

Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202

Read more

10 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Emcure Pharmaceuticals Ltd

What is the current PE Ratio of Emcure Pharmaceuticals Ltd?

The Current PE Ratio of Emcure Pharmaceuticals Ltd is 33.44 as on 1 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 1 Apr 2025.

What was the PE Ratio of Emcure Pharmaceuticals Ltd last year?

The PE Ratio of Emcure Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 33.44, showing a year-on-year growth of -%.

What does the PE Ratio of Emcure Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Emcure Pharmaceuticals Ltd is 33.44. This ratio indicates that investors are willing to pay 33.44 times the earnings per share for each share of Emcure Pharmaceuticals Ltd.

What is the PE Ratio Growth of Emcure Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Emcure Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -20.6.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions